Silvia Sabatini

TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models

Miriam Longo, Marica Meroni, Erika Paolini et al. · Cellular and Molecular Gastroenterology and Hepatology · 2021 · 109 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH

Amalia Gastaldelli, Silvia Sabatini, Fabrizia Carli et al. · Liver International · 2021 · 97 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of <scp>NASH</scp> even in lean individuals

Chiara Saponaro, Silvia Sabatini, Melania Gaggini et al. · Liver International · 2022 · 93 citations

Medicine, Endocrinology, Pathology +17

Administration of Angiotensin-Converting Enzyme Inhibitors and <i>β</i>-Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotection in the Real World?

Stefano Oliva, Giovanni Cioffi, Silvia Frattini et al. · The Oncologist · 2012 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

General Practitioner–Performed Compression Ultrasonography for Diagnosis of Deep Vein Thrombosis of the Leg: A Multicenter, Prospective Cohort Study

Nicola Mumoli, Josè Vitale, Matteo Giorgi‐Pierfranceschi et al. · The Annals of Family Medicine · 2017 · 34 citations · Full text

Medicine, Internal Medicine, Diagnostic Imaging +16